Covaxin average price realisation less than Rs 250 per dose: Bharat Biotech
Tuesday, 15 June 2021
You Might Like
💡 newsR Knowledge: Other News Mentions
Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin dosesAfter closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
After suspending Covaxin clinical trials, Brazil closes EUA requestAfter suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programmeBharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
COVID-19 vaccine for children likely by September: AIIMS ChiefIn view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.